Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SpineEX is a medical device company headquartered in Fremont, California, specializing in the development of innovative solutions for minimally invasive spine surgery. The company's primary focus is on its proprietary expandable interbody fusion technology, which allows surgeons to customize implant dimensions to a patient's specific anatomy. Its flagship product, the Sagittae Lateral Lumbar Interbody Fusion (LLIF) System, received FDA 510(k) clearance and is designed to provide independent adjustment of height and lordosis. In addition to Sagittae, SpineEX offers the Scorpio system for posterior lumbar interbody fusion procedures. By providing adjustable and minimally invasive options, SpineEX aims to improve surgical precision and enhance patient recovery times in the treatment of degenerative disc diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SpineEX.